Candesartan Desethyl Analog - Request Quote
Candesartan Desethyl Analog
| SZ CAT No: | SZ-C011019 |
| CAS No | NA |
| Mol.F. | C22H16N6O3 |
| Mol.Wt. | 412.4 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Synonym :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Candesartan Desethyl Analog is chemically 2,3-Dihydro-2-oxo-3-[[2-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-4-carboxylic acid ;. It is also known as O-Desethyl Candesartan ; . Candesartan Desethyl Analog is supplied with detailed characterization data compliant with regulatory guideline. Candesartan Desethyl Analog can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Candesartan.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Candesartan Desethyl Analog
Purchase Candesartan Desethyl Analog
Candesartan Desethyl Analog suppliers
Candesartan Desethyl Analog manufacturers
Candesartan Desethyl Analog price
Order Candesartan Desethyl Analog
Enquire Candesartan Desethyl Analog
Candesartan Desethyl Analog cost
Candesartan Desethyl Analog Supplier
Candesartan Desethyl Analog Distributor
Candesartan Desethyl Analog for Method Validation
Candesartan Reference Standard
Candesartan Desethyl Analog for ANDA Filing
Candesartan Desethyl Analog for Forced Degradation Studies
Candesartan Desethyl Analog Identification Standards
Candesartan Desethyl Analog for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


